Clinical Trials Browser

Phase 2/3 × Silymarin × Gastrointestinal × Clear all

NCT01829178 2015-05-13

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

Phase 2/3 Completed

Gastrointestinal

Gastrointestinal Neoplasms